|
The
IPO story
Small companies are becoming big. They have devised novel
ways to raise funds, fast, to realise aspirational growth.
From the various options available, IPOs remain the hot favourite
for Indian companies. Those from the Indian pharma who earlier
played safe are now making a beeline to cash in on the trend.
Nandini Patwardhan tries to understand the IPO process and
the benefits it can offer to the pharma industry
‘Revital’ising
the brand
Ranbaxy's Revital successfully shifted from prescription to
OTC and became a market leader. Sonal Shukla charts out the
transition of the Revital from a Prescription product to an
OTC brand
‘Towards
more automated cleaning’
Destin LeBlanc has been a part of the pharma industry for
more than 30 years. Now as a professional consultant, he talks
to Sonal Shukla on pharmaceutical device cleaning and validation
in the Indian context at an event held by Easy Solutions
Some
policy proposals
The National Pharmaceutical (Drug) Policy is an official document
of national government acting as a formal record of aspirations,
aims, decisions, and commitments of the government to solve
problems associated with pharmaceuticals. Dr Guru Prasad Mohanta,
Prof Dr Prabal Kumar Manna and Prof Dr R Manavalan give us
an overview of the strategies that can be adopted by the government
for effective implementation of the policy
Roche
bags the first product patent in India
Swiss drug maker F Hoffmann La-Roche achieved a milestone
by becoming the first pharmaceuticals company in India to
receive a product patent under the new patent regime.
A
lot more to patent
B K Keayla looks at the scope and issues of patentability
in the Amended Patents Act
|
